Skip to content

LouksPharma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

LouksPharma

BE 0804.096.940
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€12,820
2024 · €12,151+€669
Equity
€27,471
2024 · €14,651+€12,820
Cash
€20,101
2024 · €10,615+€9,486
Balance sheet total
€72,655
2024 · €72,998-€344

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€10,383

    down €10,383 (-22.3%), from €46,476 to €36,093

  • Cash +€9,486

    up €9,486 (+89.4%), from €10,615 to €20,101

    mainly Net result for the year (+€12,820) and Depreciation (+€11,772)

  • Receivables within one year +€819

    up €819 (+5.6%), from €14,555 to €15,374

    of which Other amounts receivable: +€2,000

Equity and liabilities
  • Debts after one year -€12,896

    down €12,896 (-45.0%), from €28,646 to €15,750

  • Reserves +€12,820

    up €12,820 (+105.5%), from €12,151 to €24,971

  • Other debts +€1,640

    up €1,640 (+99.7%), from €1,645 to €3,285

  • Trade debts -€1,488

    down €1,488 (-30.1%), from €4,942 to €3,455

  • Tax, wage and social debts -€953

    down €953 (-8.9%), from €10,751 to €9,798

    of which Taxes: -€3,474

Income statement
  • Taxes -€3,403

    down €3,403 (-69.3%), from €4,909 to €1,507

  • Depreciation +€2,166

    up €2,166 (+22.6%), from €9,606 to €11,772

  • Other operating charges +€1,027

    up €1,027 (+703.8%), from €146 to €1,173

  • Gross operating margin +€332

    up €332 (+1.2%), from €28,478 to €28,810

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €12,151
Gross operating margin +€332
Depreciation -€2,166
Other operating charges -€1,027
Financial income -€0
Financial charges +€128
Taxes +€3,403
Result 2025 €12,820

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€22,973
Investment -€1,123
Financing -€12,363
Cash 2024 €10,615
Net result for the year +€12,820
Depreciation +€11,772
Receivables within one year -€819
Deferred charges and accrued income -€0
Trade debts -€1,488
Tax, wage and social debts -€953
Other debts +€1,640
Investment in fixed assets (net) -€1,123
Debts after one year -€12,896
Current portion of long-term debt +€533
Cash 2025 €20,101
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €72,998 €72,655 -€344 -0.5%
Fixed assets 21/28 €47,102 €36,452 -€10,649 -22.6%
Intangible fixed assets 21 €572 €305 -€267 -46.6%
Tangible fixed assets 22/27 €46,476 €36,093 -€10,383 -22.3%
Furniture and vehicles 24 €46,476 €36,093 -€10,383 -22.3%
Financial fixed assets 28 €54 €54 = 0.0%
Current assets 29/58 €25,897 €36,202 +€10,306 +39.8%
Amounts receivable within one year 40/41 €14,555 €15,374 +€819 +5.6%
Trade receivables 40 €12,055 €10,874 -€1,181 -9.8%
Other amounts receivable 41 €2,500 €4,500 +€2,000 +80.0%
Cash at bank and in hand 54/58 €10,615 €20,101 +€9,486 +89.4%
Deferred charges and accrued income 490/1 €727 €727 +€0 0.0%
Total equity and liabilities 10/49 €72,998 €72,655 -€344 -0.5%
Equity 10/15 €14,651 €27,471 +€12,820 +87.5%
Contributions 10/11 €2,500 €2,500 = 0.0%
Reserves 13 €12,151 €24,971 +€12,820 +105.5%
Distributable reserves 133 €12,151 €24,971 +€12,820 +105.5%
Amounts payable 17/49 €58,347 €45,183 -€13,164 -22.6%
Amounts payable after more than one year 17 €28,646 €15,750 -€12,896 -45.0%
Financial debts 170/4 €28,646 €15,750 -€12,896 -45.0%
Amounts payable within one year 42/48 €29,701 €29,433 -€268 -0.9%
Current portion of amounts payable after more than one year 42 €12,363 €12,896 +€533 +4.3%
Trade debts 44 €4,942 €3,455 -€1,488 -30.1%
Suppliers 440/4 €4,942 €3,455 -€1,488 -30.1%
Taxes, remuneration and social security 45 €10,751 €9,798 -€953 -8.9%
Taxes 450/3 €10,334 €6,860 -€3,474 -33.6%
Remuneration and social security 454/9 €417 €2,938 +€2,521 +605.1%
Other amounts payable 47/48 €1,645 €3,285 +€1,640 +99.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,606 €11,772 +€2,166 +22.6%
Other operating charges 640/8 €146 €1,173 +€1,027 +703.8%
Gross operating margin 9900 €28,478 €28,810 +€332 +1.2%
Operating profit (loss) 9901 €18,726 €15,864 -€2,862 -15.3%
Financial income 75/76B €0 - -€0
Recurring financial income 75 €0 - -€0
Financial charges 65/66B €1,665 €1,537 -€128 -7.7%
Recurring financial charges 65 €1,665 €1,537 -€128 -7.7%
Profit (loss) for the period before taxes 9903 €17,060 €14,327 -€2,733 -16.0%
Income taxes 67/77 €4,909 €1,507 -€3,403 -69.3%
Profit (loss) for the period 9904 €12,151 €12,820 +€669 +5.5%
Profit (loss) for the period to be appropriated 9905 €12,151 €12,820 +€669 +5.5%

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.